WILSON THERAPEUTICS
Wilson Therapeutics is a biopharmaceutical company, based in Stockholm, Sweden, that develops novel therapies for patients with rare diseases such as Wilson Disease. Wilson Therapeutics’ lead product, Decuprate®, is initially being developed as a new treatment for Wilson Disease and is currently being evaluated in a Phase II clinical study in Wilson Disease patients.
WILSON THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.wilsontherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
46 8 796 00 00
Email Addresses:
[email protected]
Total Funding:
68.89 M USD
Technology used in webpage:
IPhone / Mobile Compatible SPF SSL By Default Amazon PHP 7 Amazon Route 53 Apache 2.4
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Myelo Therapeutics
Myelo Therapeutics develops innovative treatments in areas of high unmet medical needs.
Quantum Genomics
Quantum Genomics is developing therapies for unmet medical needs in the field of cardiovascular diseases
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
MVM Life Science Partners
MVM Life Science Partners investment in Series B - Wilson Therapeutics
Neomed Management
Neomed Management investment in Series B - Wilson Therapeutics
HealthCap
HealthCap investment in Series B - Wilson Therapeutics
Abingworth
Abingworth investment in Series B - Wilson Therapeutics
Official Site Inspections
http://www.wilsontherapeutics.com
- Host name: s3-website-us-east-1.amazonaws.com
- IP address: 16.182.36.109
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
